After two decades of limited advancements, a new and promising breakthrough has emerged in the fight against glioma: ...
Other targeted therapy drugs include vorasidenib (Voranigo), which blocks IDH1 and IDH2 proteins to help the tumor cells mature into more normal cells, and everolimus (Afinitor), which blocks a ...